Mel-Mont Medical

Mel-Mont Medical is a private healthcare company focused on molecular diagnostics and medical devices for the early detection and prevention of HPV-related cancers. The company develops non-invasive self-sampling devices and proprietary molecular assays centered on high-risk HPV DNA and E6/E7 mRNA detection. Its flagship commercial offerings include Mía by XytoTest for sample collection and PreTect HPV-Proofer 7 for molecular risk stratification. The company also offers in vitro diagnostics, molecular reagents, and laboratory services, and has expanded internationally through European and Latin American regulatory authorizations and distribution arrangements. Overall, Mel-Mont Medical appears to be a commercial-stage women’s health and diagnostics company rather than a therapeutics developer.